Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Urbanowicz

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Journal of Virology|December 16, 2011
Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralizationAlexander W Tarr, Richard A Urbanowicz, Dhanya Jayaraj, et al.
Antiviral Research|September 16, 2018
Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus-neutralizing antibodiesAlexander W Tarr, Matthijs Backx, Mohamed R Hamed, et al.
Journal of Medical Microbiology|September 9, 2021
Challenges on the development of a pseudotyping assay for Zika glycoproteinsFernando Ruiz-Jiménez, Jose Humberto Pérez-Olais, Chidinma Raymond, et al.
Viruses|January 8, 2025
Phlorotannin-Rich <i>Ascophyllum nodosum</i> Seaweed Extract Inhibits Influenza InfectionDaniele F Mega, Parul Sharma, Anja Kipar, et al.
The Journal of General Virology|November 1, 2015
Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAbRolando Paciello, Richard A Urbanowicz, Gennaro Riccio, et al.
The Journal of General Virology|November 18, 2022
Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virusAna Chumbe, Richard A Urbanowicz, Kwinten Sliepen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2023
Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virusAlexander I Mosa, David S Campo, Yury Khudyakov, et al.
Journal of Virology|February 18, 2011
Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotypeAlexander W Tarr, Richard A Urbanowicz, Mohamed R Hamed, et al.
Virology|March 14, 2016
Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individualsR Bridget Ferns, Alexander W Tarr, Stephane Hue, et al.
Journal of Virology|December 25, 2015
A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization ResistanceRichard A Urbanowicz, C Patrick McClure, Richard J P Brown, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Journal of Virology|December 16, 2011
Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralizationAlexander W Tarr, Richard A Urbanowicz, Dhanya Jayaraj, et al.
Antiviral Research|September 16, 2018
Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus-neutralizing antibodiesAlexander W Tarr, Matthijs Backx, Mohamed R Hamed, et al.
Journal of Medical Microbiology|September 9, 2021
Challenges on the development of a pseudotyping assay for Zika glycoproteinsFernando Ruiz-Jiménez, Jose Humberto Pérez-Olais, Chidinma Raymond, et al.
Viruses|January 8, 2025
Phlorotannin-Rich <i>Ascophyllum nodosum</i> Seaweed Extract Inhibits Influenza InfectionDaniele F Mega, Parul Sharma, Anja Kipar, et al.
The Journal of General Virology|November 1, 2015
Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAbRolando Paciello, Richard A Urbanowicz, Gennaro Riccio, et al.
The Journal of General Virology|November 18, 2022
Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virusAna Chumbe, Richard A Urbanowicz, Kwinten Sliepen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2023
Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virusAlexander I Mosa, David S Campo, Yury Khudyakov, et al.
Journal of Virology|February 18, 2011
Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotypeAlexander W Tarr, Richard A Urbanowicz, Mohamed R Hamed, et al.
Virology|March 14, 2016
Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individualsR Bridget Ferns, Alexander W Tarr, Stephane Hue, et al.
Journal of Virology|December 25, 2015
A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization ResistanceRichard A Urbanowicz, C Patrick McClure, Richard J P Brown, et al.
Pageof 6